| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |